Dil has informed that the meeting(s) of the Audit Committee and Board of Directors of the Company are scheduled to be held on May 30, 2017, to consider and approve Audited financial statements (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2017 and recommend final equity dividend, if any, for the financial year 2016-17. Further, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is hereby notified that ‘Trading Window’ (period for trading in Company’s securities) shall remain closed from May 13, 2017 till the close of business hours on June 01, 2017, for approval of the Audited financial results (Standalone and Consolidated) of the Company, for the quarter and year ended March 31, 2017 along with audited financial results for the fourth quarter (which shall be balancing figure) and recommendation of final dividend, if any for the said financial year. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares, either in their own name or in the name of their Immediate Relatives.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: